Autologous and Allogeneic CAR T-Cell Therapies: Spotlighting the “Brain-to-Vein” Time

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	134-137
Number of pages	4
Journal	Clinical Advances in Hematology and Oncology
Volume	20
Issue number	3
State	Published - Mar 2022

ASJC Scopus subject areas

@article{1fcf17f6c33749eb97b9c3e558a134ef,

title = "Autologous and Allogeneic CAR T-Cell Therapies: Spotlighting the “Brain-to-Vein” Time",

author = "Matthew Lunning",

year = "2022",

month = mar,

language = "English (US)",

volume = "20",

pages = "134--137",

journal = "Clinical Advances in Hematology and Oncology",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "3",

}

TY - JOUR

T1 - Autologous and Allogeneic CAR T-Cell Therapies

T2 - Spotlighting the “Brain-to-Vein” Time

AU - Lunning, Matthew

PY - 2022/3

Y1 - 2022/3

UR - http://www.scopus.com/inward/record.url?scp=85126811236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85126811236&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 36607341

AN - SCOPUS:85126811236

SN - 1543-0790

VL - 20

SP - 134

EP - 137

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

IS - 3

ER -